ATRA – Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc.ATRA
$6.17Name : Atara Biotherapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $36,149,476.00
EPSttm : -11.41
Atara Biotherapeutics, Inc.
$6.17
5.65%$0.33Float Short %
17.73
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.13
EPS Last/This Y
5.61
EPS This/Next Y
4.42
Price
6.17
Target Price
13.25
Analyst Recom
1.67
Performance Q
-21.2
Relative Volume
0.17
Beta
0.34
Ticker: ATRA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | ATRA | 6.74 | N/A | N/A | 0 |
| 2025-03-21 | ATRA | 6.6 | N/A | N/A | 0 |
| 2025-03-24 | ATRA | 6.95 | N/A | N/A | 0 |
| 2025-03-25 | ATRA | 6.9 | N/A | N/A | 0 |
| 2025-03-26 | ATRA | 6.62 | N/A | N/A | 0 |
| 2025-03-27 | ATRA | 6.9 | N/A | N/A | 0 |
| 2025-03-28 | ATRA | 6.53 | N/A | N/A | 0 |
| 2025-03-31 | ATRA | 5.92 | N/A | N/A | 0 |
| 2025-04-01 | ATRA | 6.01 | N/A | N/A | 0 |
| 2025-04-02 | ATRA | 6.12 | N/A | N/A | 0 |
| 2025-04-03 | ATRA | 5.87 | N/A | N/A | 0 |
| 2025-04-04 | ATRA | 5.72 | N/A | N/A | 0 |
| 2025-04-07 | ATRA | 5.7 | N/A | N/A | 0 |
| 2025-04-08 | ATRA | 5.58 | N/A | N/A | 0 |
| 2025-04-09 | ATRA | 5.85 | N/A | N/A | 0 |
| 2025-04-10 | ATRA | 5.26 | N/A | N/A | 0 |
| 2025-04-11 | ATRA | 5.48 | N/A | N/A | 0 |
| 2025-04-14 | ATRA | 5.73 | N/A | N/A | 0 |
| 2025-04-15 | ATRA | 5.97 | N/A | N/A | 0 |
| 2025-04-16 | ATRA | 5.73 | N/A | N/A | 0 |
| 2025-04-17 | ATRA | 6.16 | N/A | N/A | 0 |
| 2025-04-18 | ATRA | 6.17 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | ATRA | 6.74 | 62.0 | - | -5.84 |
| 2025-03-21 | ATRA | 6.69 | 62.0 | - | -5.84 |
| 2025-03-24 | ATRA | 6.94 | 62.0 | - | -5.84 |
| 2025-03-25 | ATRA | 6.92 | 62.0 | - | -5.84 |
| 2025-03-26 | ATRA | 6.62 | 62.0 | - | -5.84 |
| 2025-03-27 | ATRA | 6.82 | 62.0 | - | -5.84 |
| 2025-03-28 | ATRA | 6.53 | 62.0 | - | -5.84 |
| 2025-03-31 | ATRA | 5.88 | 62.0 | - | -5.84 |
| 2025-04-01 | ATRA | 6.01 | 62.0 | - | -5.84 |
| 2025-04-02 | ATRA | 6.13 | 62.0 | - | -5.84 |
| 2025-04-03 | ATRA | 5.89 | 62.0 | - | -5.84 |
| 2025-04-04 | ATRA | 5.78 | 66.5 | - | -5.80 |
| 2025-04-07 | ATRA | 5.65 | 66.5 | - | -5.80 |
| 2025-04-08 | ATRA | 5.59 | 66.5 | - | -5.80 |
| 2025-04-09 | ATRA | 5.85 | 66.5 | - | -5.80 |
| 2025-04-10 | ATRA | 5.26 | 66.5 | - | -5.80 |
| 2025-04-11 | ATRA | 5.34 | 66.5 | - | -5.80 |
| 2025-04-14 | ATRA | 5.85 | 66.5 | - | -5.80 |
| 2025-04-15 | ATRA | 5.98 | 66.5 | - | -5.80 |
| 2025-04-16 | ATRA | 5.84 | 66.5 | - | -5.80 |
| 2025-04-17 | ATRA | 6.17 | 66.5 | - | -5.80 |
| 2025-04-18 | ATRA | 6.17 | 66.5 | - | -5.80 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | ATRA | -0.47 | 22.50 | 18.82 |
| 2025-03-21 | ATRA | -0.47 | 22.50 | 18.82 |
| 2025-03-24 | ATRA | -0.47 | 22.94 | 18.82 |
| 2025-03-25 | ATRA | -0.47 | 22.94 | 18.82 |
| 2025-03-26 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-03-27 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-03-28 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-03-31 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-04-01 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-04-02 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-04-03 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-04-04 | ATRA | -0.47 | 22.94 | 19.03 |
| 2025-04-07 | ATRA | -0.47 | 23.34 | 19.03 |
| 2025-04-08 | ATRA | -0.47 | 23.34 | 19.03 |
| 2025-04-09 | ATRA | -0.47 | 23.34 | 19.03 |
| 2025-04-10 | ATRA | -0.47 | 23.34 | 17.55 |
| 2025-04-11 | ATRA | -0.47 | 23.34 | 17.55 |
| 2025-04-14 | ATRA | -0.47 | 23.33 | 17.73 |
| 2025-04-15 | ATRA | -0.46 | 23.33 | 17.73 |
| 2025-04-16 | ATRA | -0.46 | 23.33 | 17.73 |
| 2025-04-17 | ATRA | -0.46 | 23.33 | 17.73 |
| 2025-04-18 | ATRA | -0.46 | 23.33 | 17.73 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.19
Avg. EPS Est. Current Quarter
-2.19
Avg. EPS Est. Next Quarter
-1.32
Insider Transactions
-0.46
Institutional Transactions
23.33
Beta
0.34
Average Sales Estimate Current Quarter
3
Average Sales Estimate Next Quarter
4
Fair Value
Quality Score
69
Growth Score
32
Sentiment Score
68
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.2
Target Price
13.25
P/E
Forward P/E
PEG
P/S
0.28
P/B
P/Free Cash Flow
EPS
-12.87
Average EPS Est. Cur. Y
-5.8
EPS Next Y. (Est.)
-1.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-66.23
Relative Volume
0.17
Return on Equity vs Sector %
67.8
Return on Equity vs Industry %
81.2
EPS 1 7Days Diff
EPS 1 30Days Diff
2.24
EBIT Estimation
Atara Biotherapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 153
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
stock quote shares ATRA – Atara Biotherapeutics, Inc. Stock Price stock today
news today ATRA – Atara Biotherapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ATRA – Atara Biotherapeutics, Inc. yahoo finance google finance
stock history ATRA – Atara Biotherapeutics, Inc. invest stock market
stock prices ATRA premarket after hours
ticker ATRA fair value insiders trading